Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 80,000 shares at $35.57 ($2.8M) on 2021-08-23, disclosed to the SEC on 2021-08-25.
Open-market sale of $2.8M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.07 | 40,000 | $1.4M | 49.6% |
| 2 | $35.57 | 10,000 | $356K | 12.6% |
| 3 | $35.57 | 30,000 | $1.1M | 37.8% |
| Total | $35.32 avg | 80,000 | $2.8M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |
| MYGN | SELL | 2021-07-12 | $3.3M | — | Filing → |